Skip to main content
. 2017 Nov 6;9(10):8887–8897. doi: 10.18632/oncotarget.22322

Figure 5. Mimic-1 is effective against chemoresistant colon cancer stem cells (CSCs).

Figure 5

(A) 100 nM Mimic-1 reduces CSCs viability by 80% while 100 μM 5-FU has minimal effect. (B) Mimic-1 reduces the expression of targets E2F3 and BCL2 in colon CSCs. (C) Mimic-1 can inhibit proliferation of colon CSCs. (D) Mimic-1 inhibits sphere formation in colon CSCs. (E) Mimic-1 induces apoptosis in colon CSCs. (**p<0.01; ***p<0.001).